{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:38:47Z","timestamp":1781836727766,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,3,10]],"date-time":"2007-03-10T00:00:00Z","timestamp":1173484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2007,10,30]]},"DOI":"10.1007\/s10549-007-9507-x","type":"journal-article","created":{"date-parts":[[2007,3,9]],"date-time":"2007-03-09T08:02:07Z","timestamp":1173427327000},"page":"389-397","source":"Crossref","is-referenced-by-count":42,"title":["A phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women"],"prefix":"10.1007","volume":"106","author":[{"given":"Robert","family":"Mansel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Le","family":"Nestour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Masini-Et\u00e9v\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Afimoxifene (4-OHT) Breast Pain Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,10]]},"reference":[{"issue":"1","key":"9507_CR1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0002-9378(97)70450-2","volume":"177","author":"DN Ader","year":"1997","unstructured":"Ader DN, Browne MW (1997) Prevalence and impact of cyclic mastalgia in a United States clinic-based sample. Am J Obstet Gynecol 177(1):126\u2013132","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"9507_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/01674820109049956","volume":"22","author":"DN Ader","year":"2001","unstructured":"Ader DN, South-Paul J, Adera T, Deuster PA. (2001) Cyclical mastalgia: prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol 22(2):71\u201376","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"5","key":"9507_CR3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0002-9378(97)70392-2","volume":"176","author":"PJ Goodwin","year":"1997","unstructured":"Goodwin PJ, Miller A, Del Giudice ME, Ritchie K (1997) Breast health and associated premenstrual symptoms in women with severe cyclic mastopathy. Am J Obstet Gynecol 176(5):998\u20131005","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"9507_CR4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2105\/AJPH.72.11.1257","volume":"72","author":"NF Woods","year":"1982","unstructured":"Woods NF, Most A, Dery GK (1982) Prevalence of perimenstrual symptoms. Am J Public Health 72(11):1257\u20131264","journal-title":"Am J Public Health"},{"issue":"3","key":"9507_CR5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2105\/AJPH.77.3.349","volume":"77","author":"CA Boyle","year":"1987","unstructured":"Boyle CA, Berkowitz GS, Kelsey JL (1987) Epidemiology of premenstrual symptoms. Am J Public Health 77(3):349\u2013350","journal-title":"Am J Public Health"},{"issue":"7987","key":"9507_CR6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0140-6736(76)92477-6","volume":"2","author":"PE Preece","year":"1976","unstructured":"Preece PE, Mansel RE, Bolton PM, Hughes LM, Baum M, Gravelle IH (1976) Clinical syndromes of mastalgia. Lancet 2(7987):670\u2013673","journal-title":"Lancet"},{"issue":"5","key":"9507_CR7","first-page":"482","volume":"185","author":"DN Ader","year":"1997","unstructured":"Ader DN, Shriver CD (1997) Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample. J Am Coll Surg 185(5):482\u2013486","journal-title":"J Am Coll Surg"},{"issue":"6","key":"9507_CR8","first-page":"610","volume":"20","author":"M Deschamps","year":"1996","unstructured":"Deschamps M, Band PR, Coldman AJ, Hislop TG, Longley DJ (1996) Clinical determinants of mammographic dysplasia patterns. Cancer Detect Prev 20(6):610\u2013619","journal-title":"Cancer Detect Prev"},{"issue":"1","key":"9507_CR9","first-page":"5","volume":"95","author":"AK Khanna","year":"1997","unstructured":"Khanna AK, Tapodar J, Misra MK (1997) Spectrum of benign breast disorders in a university hospital. J Indian Med Assoc 95(1):5\u20138","journal-title":"J Indian Med Assoc"},{"issue":"3","key":"9507_CR10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/bjs.1800740324","volume":"74","author":"SJ Leinster","year":"1987","unstructured":"Leinster SJ, Whitehouse GH, Walsh PV (1987) Cyclical mastalgia: clinical and mammographic observations in a screened population. Br J Surg 74(3):220\u2013222","journal-title":"Br J Surg"},{"issue":"2","key":"9507_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1019685829799","volume":"75","author":"SA Khan","year":"2002","unstructured":"Khan SA, Apkarian AV (2002) The characteristics of cyclical and non-cyclical mastalgia: a prospective study using a modified McGill Pain Questionnaire. Breast Cancer Res Treat 75(2):147\u2013157","journal-title":"Breast Cancer Res Treat"},{"issue":"8278","key":"9507_CR12","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(82)91932-8","volume":"1","author":"RE Mansel","year":"1982","unstructured":"Mansel RE, Wisbey JR, Hughes LE (1982) Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease. Lancet 1(8278):928\u2013930","journal-title":"Lancet"},{"issue":"8683","key":"9507_CR13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0140-6736(90)90278-D","volume":"335","author":"RE Mansel","year":"1990","unstructured":"Mansel RE, Dogliotti L (1990) European multicentre trial of bromocriptine in cyclical mastalgia. Lancet 335(8683):190\u2013193","journal-title":"Lancet"},{"issue":"8476","key":"9507_CR14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(86)90825-1","volume":"1","author":"IS Fentiman","year":"1986","unstructured":"Fentiman IS, Caleffi M, Brame K, Chaudary MA, Hayward JL (1986) Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1(8476):287\u2013288","journal-title":"Lancet"},{"issue":"9","key":"9507_CR15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/bjs.1800750905","volume":"75","author":"IS Fentiman","year":"1988","unstructured":"Fentiman IS, Caleffi M, Hamed H, Chaudary MA (1988) Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg 75(9):845\u2013846","journal-title":"Br J Surg"},{"issue":"2","key":"9507_CR16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1677\/joe.0.0750305","volume":"75","author":"VC Jordan","year":"1977","unstructured":"Jordan VC, Collins MM, Rowsby L, Prestwich G (1977) A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. J Endocrinol 75(2):305\u2013316","journal-title":"J Endocrinol"},{"issue":"3","key":"9507_CR17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","volume":"138","author":"GG Kuiper","year":"1997","unstructured":"Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S et al (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138(3):863\u2013870","journal-title":"Endocrinology"},{"issue":"24 Pt 1","key":"9507_CR18","first-page":"7193","volume":"48","author":"C Malet","year":"1988","unstructured":"Malet C, Gompel A, Spritzer P, Bricout N, Yaneva H, Mowszowicz I et al (1988) Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture. Cancer Res 48(24 Pt 1):7193\u20137199","journal-title":"Cancer Res"},{"issue":"1","key":"9507_CR19","first-page":"112","volume":"44","author":"BS Katzenellenbogen","year":"1984","unstructured":"Katzenellenbogen BS, Norman MJ, Eckert RL, Peltz SW, Mangel WF (1984) Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res 44(1):112\u2013119","journal-title":"Cancer Res"},{"issue":"13","key":"9507_CR20","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1200\/JCO.2005.06.064","volume":"23","author":"P Rouanet","year":"2005","unstructured":"Rouanet P, Linares-Cruz G, Dravet F, Poujol S, Gourgou S, Simony-Lafontaine J et al (2005) Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4 OHT gel to oral tamoxifen. J Clin Oncol 23(13):2980\u20132987","journal-title":"J Clin Oncol"},{"key":"9507_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1072-7515(02)01893-8","volume":"196","author":"T Colak","year":"2003","unstructured":"Colak T, Ipek T, Kanik A, Ogetman Z, Aydin S (2003) Efficacy of topical nonsteroidal anti-inflammatory drugs in mastalgia treatment. J Am Coll Surg 196:525\u2013530","journal-title":"J Am Coll Surg"},{"issue":"3","key":"9507_CR22","first-page":"158","volume":"43","author":"AD Irving","year":"1998","unstructured":"Irving AD, Morrison SL (1998) Effectiveness of topical non-steroidal anti-inflammatory drugs in the management of breast pain. J R Coll Surg Edinb 43(3):158\u2013159","journal-title":"J R Coll Surg Edinb"},{"issue":"1","key":"9507_CR23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","volume":"17","author":"DD Price","year":"1983","unstructured":"Price DD, McGrath PA, Rafii A, Buckingham B (1983) The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 17(1):45\u201356","journal-title":"Pain"},{"issue":"4","key":"9507_CR24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0412.1988.tb07804.x","volume":"67","author":"IE Messinis","year":"1988","unstructured":"Messinis IE, Lolis D (1988) Treatment of premenstrual mastalgia with tamoxifen. Acta Obstet Gynecol Scand 67(4):307\u2013309","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"9507_CR25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/09513599709152566","volume":"11","author":"E Kontostolis","year":"1997","unstructured":"Kontostolis E, Stefanidis K, Navrozoglou I, Lolis D (1997) Comparison of tamoxifen with danazol for treatment of cyclical mastalgia. Gynecol Endocrinol 11(6):393\u2013397","journal-title":"Gynecol Endocrinol"},{"issue":"19","key":"9507_CR26","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","volume":"20","author":"TJ Smith","year":"2002","unstructured":"Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL et al (2002) Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 20(19):4040\u20134049","journal-title":"J Clin Oncol"},{"issue":"4","key":"9507_CR27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0885-3924(96)00191-1","volume":"12","author":"JE Hammack","year":"1996","unstructured":"Hammack JE, Mailliard JA, Loprinzi CL, Rospond RM, O\u2019Fallon JR, Wilwerding MB et al (1996) Transdermal fentanyl in the management of cancer pain in ambulatory patients: an open-label pilot study. J Pain Symptom Manage 12(4):234\u2013240","journal-title":"J Pain Symptom Manage"},{"key":"9507_CR28","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ajog.2004.06.100","volume":"191","author":"RE Mansel","year":"2004","unstructured":"Mansel RE, Goyal A, Preece P et al (2004) European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia. Am J Obstet Gynecol 191:1942\u20131949","journal-title":"Am J Obstet Gynecol"},{"key":"9507_CR29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1075-122X.2005.21492.x","volume":"11","author":"A Goyal","year":"2005","unstructured":"Goyal A, Mansel RE (2005) on behalf of the Efamast Study Group. A Randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J 11:41\u201347","journal-title":"Breast J"},{"issue":"18","key":"9507_CR30","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371\u20131388","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"9507_CR31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/B:BREA.0000021050.92539.b0","volume":"85","author":"L Gallicchio","year":"2004","unstructured":"Gallicchio L, Lord G, Tkaczuk K, Danton M, Lewis LM, Lim CK et al (2004) Association of tamoxifen (TAM) and TAM metabolite concentrations with self-reported side effects of TAM in women with breast cancer. Breast Cancer Res Treat 85(1):89\u201397","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"9507_CR32","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1054\/bjoc.2000.1120","volume":"82","author":"J MacCallum","year":"2000","unstructured":"MacCallum J, Cummings J, Dixon JM, Miller WR (2000) Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours. Br J Cancer 82(10):1629\u20131635","journal-title":"Br J Cancer"},{"issue":"5 Pt 2","key":"9507_CR33","first-page":"855","volume":"97","author":"MJ Mourits","year":"2001","unstructured":"Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG (2001) Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 97(5 Pt 2):855\u2013866","journal-title":"Obstet Gynecol"},{"issue":"4","key":"9507_CR34","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ajog.2004.12.083","volume":"192","author":"E Chalas","year":"2005","unstructured":"Chalas E, Costantino JP, Wickerham DL, Wolmark N, Lewis GC, Bergman C et al (2005) Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial. Am J Obstet Gynecol 192(4):1230\u20131237","journal-title":"Am J Obstet Gynecol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9507-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-007-9507-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9507-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:28:48Z","timestamp":1559219328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-007-9507-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,10]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,10,30]]}},"alternative-id":["9507"],"URL":"https:\/\/doi.org\/10.1007\/s10549-007-9507-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,10]]}}}